Skip to main content
logo
Titan Pharmaceuticals, Inc. (TTNP)
Oct 2, 2025 - TTNP was delisted (reason: merged into BTTC).
4.610
-0.180 (-3.76%)
Inactive · Last trade price on Oct 1, 2025

Titan Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
636111023
Market Cap Growth
20.24%-52.04%-45.75%13.29%-56.58%109.11%
Enterprise Value
3-1-17325
Last Close Price
4.613.268.2515.6620.4065.80

Price Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
--33.7820.576.634.81
PB Ratio
2.201.220.948.401.976.59
P/TBV Ratio
2.201.220.948.401.976.59

EV Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
EV/Sales Ratio
---12.971.985.08

Financial Efficiency

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Debt / Equity Ratio
--0.090.140.060.23
Asset Turnover
--0.030.090.190.55
Inventory Turnover
---23.8518.9714.34
Quick Ratio
11.205.994.711.132.301.49
Current Ratio
11.606.055.551.372.711.74
Return on Equity (ROE)
-82.72%-103.63%-139.14%-313.98%-202.44%-298.37%
Return on Assets (ROA)
-44.08%-51.74%-74.90%-106.15%-72.71%-52.18%
Return on Invested Capital (ROIC)
-48.10%-59.05%-103.87%-183.11%-119.58%-89.95%

Yields

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Earnings Yield
-45.74%-157.90%-89.61%-89.09%-86.78%-78.33%
FCF Yield
-44.78%-130.18%-114.15%-71.43%-78.34%-76.19%
Buyback Yield / Dilution
-16.31%-19.55%-11.91%-38.13%-157.89%-392.56%
SEC Filings: 10-K · 10-Q